Paul Andrew Moore - Net Worth and Insider Trading
Paul Andrew Moore Net Worth
The estimated net worth of Paul Andrew Moore is at least $106,232 dollars as of 2024-11-29. Paul Andrew Moore is the Chief Scientific Officer of Zymeworks Inc and owns about 7,367 shares of Zymeworks Inc (ZYME) stock worth over $106,232. Details can be seen in Paul Andrew Moore's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Andrew Moore has not made any transactions after 2024-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Andrew Moore
Paul Andrew Moore Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Andrew Moore owns 1 companies in total, including Zymeworks Inc (ZYME) .
Click here to see the complete history of Paul Andrew Moore’s form 4 insider trades.
Insider Ownership Summary of Paul Andrew Moore
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZYME | Zymeworks Inc | 2024-01-08 | Chief Scientific Officer |
Paul Andrew Moore Latest Holdings Summary
Paul Andrew Moore currently owns a total of 1 stock. Paul Andrew Moore owns 7,367 shares of Zymeworks Inc (ZYME) as of January 8, 2024, with a value of $106,232.
Latest Holdings of Paul Andrew Moore
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZYME | Zymeworks Inc | 2024-01-08 | 7,367 | 14.42 | 106,232 |
Holding Weightings of Paul Andrew Moore
Paul Andrew Moore Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Andrew Moore has made a total of 1 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zymeworks Inc is the sale of 9,799 shares on January 8, 2024, which brought Paul Andrew Moore around $105,731.
Insider Trading History of Paul Andrew Moore
- 1
Paul Andrew Moore Trading Performance
Paul Andrew Moore Ownership Network
Paul Andrew Moore Owned Company Details
What does Zymeworks Inc do?
Who are the key executives at Zymeworks Inc?
Paul Andrew Moore is the Chief Scientific Officer of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and 10 percent owner Ecor1 Capital, Llc .
Zymeworks Inc (ZYME) Insider Trades Summary
Over the past 18 months, Paul Andrew Moore made 1 insider transaction in Zymeworks Inc (ZYME) with a net sale of 9,799. Other recent insider transactions involving Zymeworks Inc (ZYME) include a net sale of 6,880 shares made by Christopher Astle , a net purchase of 3,350,000 shares made by Ecor1 Capital, Llc , and a net sale of 23,904 shares made by Kenneth Galbraith .
In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,583 shares of Zymeworks Inc (ZYME) were sold and 3,350,000 shares were bought by its insiders, resulting in a net purchase of 3,309,417 shares.
Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zymeworks Inc Insider Transactions
Paul Andrew Moore Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Andrew Moore. You might contact Paul Andrew Moore via mailing address: 114 East 4th Avenue, Suite 800, Vancouver A1 V5t 1g4.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
